TELA Bio, Inc. (TELA)

4.7500 -0.4000 (-7.77%) At close: 04:00PM EDT

TELA Bio, Inc.

1 Great Valley Parkway
Suite 24
Malvern, PA 19355
United States
484 320 2930
https://www.telabio.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 227

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Antony Koblish	Co-founder, President, CEO & Director	967.67k	N/A	1966
Mr. Roberto E. Cuca J.D.	CFO & COO	643.37k	N/A	1968
Ms. Megan Smeykal	VP, Corporate Controller, Chief Accounting Officer & Principal Accounting Officer	N/A	N/A	1976
Mr. D. Taylor Ocasio	General Counsel & Corporate Secretary	N/A	N/A	N/A
Ms. Jennifer Lou Armstrong	Senior Vice President of Human Resources	N/A	N/A	1970
Mr. Michael Leonard	Senior Vice President of Technical Operations	N/A	N/A	N/A
Mr. Peter C. Murphy	Chief Commercial Officer	542.34k	N/A	1973
Louisa Smith	Investor Relations Contact Officer	N/A	N/A	N/A

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

Corporate governance

TELA Bio, Inc.’s ISS governance QualityScore as of 1 April 2024 is 7. The pillar scores are Audit: 7; Board: 5; Shareholder rights: 8; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.